ARWR שולי הרווח הגולמי Arrowhead Corp

סמלים רשמיים של חברת Arrowhead Pharma (ARWR)

Arrowhead Pharmaceuticals (ARWR) develops advanced gene silencing methods to combat liver pathologies. This chart of average gross margin provided by GURU.Markets shows the status of the parameter at the 93.70 level. A team of ambitious scientists is retained through stock options, while high research costs during preparations for scaling sales temporarily constrain the company's bottom-line net profit.

arrowheadpharma.com (ARWR): שולי רווח גולמי מ-04.07.2022 עד 20.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור Arrowhead Corp (ARWR)

- מחיר מניה ומחיר יעד קונצנזוס:
הערכת שווי פונדמנטלית:Arrowhead Pharmaceuticals Inc
מוצר ממותג של Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals (ARWR) is developing high-tech centers for the creation of genetic medicines, leveraging its RNA interference platform and strategic alliances with global pharma behemoths. Analyzing this gross margin chart, an investor can see the portion of revenue remaining after direct production costs, where any sharp fluctuations in the indicator signal instability in operational efficiency and potential risks to asset value.